BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 29433016)

  • 1. Self-sampling with HPV mRNA analyses from vagina and urine compared with cervical samples.
    Asciutto KC; Ernstson A; Forslund O; Borgfeldt C
    J Clin Virol; 2018 Apr; 101():69-73. PubMed ID: 29433016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of urine, self-collected vaginal swab, and cervical swab samples for detecting human papillomavirus (HPV) with Roche Cobas HPV, Anyplex II HPV, and RealTime HR-S HPV assay.
    Cho HW; Ouh YT; Hong JH; Min KJ; So KA; Kim TJ; Paik ES; Lee JW; Moon JH; Lee JK
    J Virol Methods; 2019 Jul; 269():77-82. PubMed ID: 30998958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaginal and Urine Self-sampling Compared to Cervical Sampling for HPV-testing with the Cobas 4800 HPV Test.
    Asciutto KC; Henningsson AJ; Borgfeldt H; Darlin L; Borgfeldt C
    Anticancer Res; 2017 Aug; 37(8):4183-4187. PubMed ID: 28739704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions.
    Sellors JW; Lorincz AT; Mahony JB; Mielzynska I; Lytwyn A; Roth P; Howard M; Chong S; Daya D; Chapman W; Chernesky M
    CMAJ; 2000 Sep; 163(5):513-8. PubMed ID: 11006761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VALHUDES: A protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples.
    Arbyn M; Peeters E; Benoy I; Vanden Broeck D; Bogers J; De Sutter P; Donders G; Tjalma W; Weyers S; Cuschieri K; Poljak M; Bonde J; Cocuzza C; Zhao FH; Van Keer S; Vorsters A
    J Clin Virol; 2018 Oct; 107():52-56. PubMed ID: 30195193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cobas 4800 HPV detection in the cervical, vaginal and urine samples of women with high-grade CIN before and after treatment.
    Stanczuk GA; Currie H; Baxter G; Foster A; Gibson L; Graham C; Cuschieri K
    J Clin Pathol; 2015 Jul; 68(7):567-70. PubMed ID: 25878328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased HPV detection by the use of a pre-heating step on vaginal self-samples analysed by Aptima HPV assay.
    Borgfeldt C; Forslund O
    J Virol Methods; 2019 Aug; 270():18-20. PubMed ID: 31002831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer.
    Wright TC; Denny L; Kuhn L; Pollack A; Lorincz A
    JAMA; 2000 Jan; 283(1):81-6. PubMed ID: 10632284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of self-collected vaginal specimens for the detection of high-risk human papillomavirus infection and the prediction of high-grade cervical intraepithelial lesions in a high-burden, low-resource setting.
    Toliman PJ; Kaldor JM; Badman SG; Phillips S; Tan G; Brotherton JML; Saville M; Vallely AJ; Tabrizi SN
    Clin Microbiol Infect; 2019 Apr; 25(4):496-503. PubMed ID: 29906593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical validation of hrHPV testing on vaginal and urine self-samples in primary cervical screening (cross-sectional results from the Papillomavirus Dumfries and Galloway-PaVDaG study).
    Stanczuk G; Baxter G; Currie H; Lawrence J; Cuschieri K; Wilson A; Arbyn M
    BMJ Open; 2016 Apr; 6(4):e010660. PubMed ID: 27113237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [HPV E6 and E7 mRNA combined with HPV 16 and 18 or 45 genotyping testing as a means of cervical cancer opportunistic screening].
    Wang JJ; Dong J; Deng ZX; Wang PF; Zhang XX; Du Y
    Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):301-306. PubMed ID: 31154710
    [No Abstract]   [Full Text] [Related]  

  • 12. Are vaginal swabs comparable to cervical smears for human papillomavirus DNA testing?
    Coorevits L; Traen A; Bingé L; Van Dorpe J; Praet M; Boelens J; Padalko E
    J Gynecol Oncol; 2018 Jan; 29(1):e8. PubMed ID: 29185266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of vaginal self-sampling and cervical sampling by medical professionals for the detection of HPV and CIN2+: A randomized study.
    Aarnio R; Isacson I; Sanner K; Gustavsson I; Gyllensten U; Olovsson M
    Int J Cancer; 2021 Jun; 148(12):3051-3059. PubMed ID: 33497465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance and Diagnostic Accuracy of Human Papillomavirus Testing on Self-Collected Urine and Vaginal Samples in a Referral Population.
    Cho HW; Hong JH; Min KJ; Ouh YT; Seong SJ; Moon JH; Cho SH; Lee JK
    Cancer Res Treat; 2021 Jul; 53(3):829-836. PubMed ID: 33421987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-risk human papillomavirus messenger RNA testing in physician- and self-collected specimens for cervical lesion detection in high-risk women, Kenya.
    Ting J; Mugo N; Kwatampora J; Hill C; Chitwa M; Patel S; Gakure H; Kimani J; Schoenbach VJ; Poole C; Smith JS
    Sex Transm Dis; 2013 Jul; 40(7):584-9. PubMed ID: 23965776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive Value of HPV Testing in Self-collected and Clinician-Collected Samples Compared with Cytology in Detecting High-grade Cervical Lesions.
    El-Zein M; Bouten S; Louvanto K; Gilbert L; Gotlieb WH; Hemmings R; Behr MA; Franco EL;
    Cancer Epidemiol Biomarkers Prev; 2019 Jul; 28(7):1134-1140. PubMed ID: 31015201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective double-blind cross-sectional study of the accuracy of the use of dry vaginal tampons for self-sampling of human papillomaviruses.
    Khan AM; Sasieni P; Singer A
    BJOG; 2015 Feb; 122(3):388-94. PubMed ID: 25088393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Performance of Self-collected Specimen HPV-DNA vs Clinician- collected Specimen HPV-mRNA to Detect High-risk HPV and High-grade Cervical Lesions and Cancer.
    Kittisiam T; Chanpanitkitchot S; Tangjitgamol S; Srijaipracharoen S; Manusirivithaya S; Srisomboon J; Termrungruanglert W
    Asian Pac J Cancer Prev; 2024 Jan; 25(1):211-217. PubMed ID: 38285786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a new APTIMA specimen collection and transportation kit for high-risk human papillomavirus E6/E7 messenger RNA in cervical and vaginal samples.
    Chernesky M; Jang D; Gilchrist J; Elit L; Lytwyn A; Smieja M; Dockter J; Getman D; Reid J; Hill C
    Sex Transm Dis; 2014 Jun; 41(6):365-8. PubMed ID: 24825332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urine collection in cervical cancer screening - analytical comparison of two HPV DNA assays.
    Tranberg M; Jensen JS; Bech BH; Andersen B
    BMC Infect Dis; 2020 Dec; 20(1):926. PubMed ID: 33276740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.